(Total Views: 558)
Posted On: 01/11/2021 2:21:30 PM
Post# of 155845
The FDA won't be nearly as interested in RO as in clinical outcomes... NEWS2 is way more useful. RO could also delay results, not to mention, everyone forgets the BLA / RO debacle?
It would be nice to peek, but not at that cost.
It would be nice to peek, but not at that cost.
(4)
(0)
